Mtl1 Leucoflex Kit
NDC Package 14498-001-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Mtl1 Leucoflex (anticoagulant citrate phosphate dextrose solution with as-1) kits is a human prescription drug administered via intravenous route. This formulation utilizes a kit delivery system. Marketed by Maco Productions, this product is identified by NDC 14498-001 and is authorized under FDA application BN040083.

Identification & Billing

NDC Package Code
14498-001-01
Package Description
1 KIT in 1 KIT
Product Code
14498-001
11-Digit Billing Format
14498000101

Clinical Specifications

Proprietary Name
Mtl1 Leucoflex
Non-Proprietary Name
Anticoagulant Citrate Phosphate Dextrose Solution With As-1
Dosage Form
Kit - A packaged collection of related material.
Administration Route
Intravenous - Administration within or into a vein or veins.

Regulatory & Marketing

Labeler Name
Maco Productions
Product Type
Human Prescription Drug
FDA Application #
BN040083
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
11-21-2005
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 14498-001-01 identifies a specific commercial package of 1 kit in 1 kit of Mtl1 Leucoflex, a human prescription drug labeled by Maco Productions. This kit is formulated for intravenous use and contains as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Maco Productions on November 21, 2005. The current certification is valid through December 31, 2026.

How is this Maco Productions product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 14498000101. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
14498-001-01
11-Digit CMS (5-4-2)
14498-0001-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.